1. Drug name
ENTERMINGO
2. Drug formula ingredients
Bacillus Clausii2 x 109 CFU/5ml
3. Dosage form
Oral suspension.
4. Route of administration
Oral route.
5. Indications
- Treatment and prevention of intestinal dysbiosis and endogenous vitamin malabsorption.
- Supportive treatment to restore intestinal flora affected when using antibiotics or chemotherapy.
- Acute & chronic digestive disorders in children due to poisoning or intestinal dysbiosis & vitamin malabsorption.
6. Administration, dosage
Dosage
Adults: 2-3 tubes/day. Children: 1-2 tubes/day. Young children: 1-2 tubes/day.
Administration
Take the medicine about 3-4 hours apart, mix the medicine in the tube with sugar water, milk, tea or orange juice.
7. Contraindications
Patients who are allergic or sensitive to any ingredient of the drug.
8. Special warnings and precautions for use
When you are being treated with antibiotics, you should take this medicine in between the intervals of taking antibiotics.
9. Fertility, pregnancy and lactation
Pregnant
Medicines used during pregnancy can cause bad effects (miscarriage, birth defects, fetal malformations...) at any stage of pregnancy development, especially the first three months. Therefore, it is best not to use the drug for pregnant women. In case you must use it, you should carefully consult your doctor or pharmacist before deciding.
Breastfeeding women
Medicines can be passed to the baby through breastfeeding. It is best not to or limit the use of medication during breastfeeding. Many drugs have unknown effects during this period. Mothers need to carefully read the instructions for use and consult a doctor or pharmacist before deciding to use the drug.
10. Effects on ability to drive and use machines
The drug does not affect the ability to drive and operate machinery.
11. Interaction with other medicinal products and other forms of interaction
Food and drink do not affect the effectiveness of Bacillus clausii.
12. Undesirable effects
There have been no reports of side effects when using Bacillus clausii.
13. Overdose
There have been no reports of overdose when using Bacillus clausii .
14. Pharmacodynamic properties
When taking Bacillus clausii spores, thanks to their strong resistance to chemical and physical agents, the drug passes intact through the gastric acid barrier, enters the digestive tract and transforms into reproductive cells. nutrients capable of metabolic activity.
Thanks to the effects of Bacillus clausii, Bacillus clausii, when taken orally, contributes to restoring intestinal flora that has been altered due to many sources. Furthermore, because Bacillus clausii has the ability to produce some special vitamins, B vitamins also contribute to supplementing vitamin deficiencies caused by the use of antibiotics and chemotherapy.
Bacillus clausii can help produce non-specific antibodies and has a detoxifying effect, which is closely related to the metabolic effects of Bacillus clausii. In addition, the high level of resistance to antibiotics of bacterial strains due to artificial selection, provides the basis for treatment to prevent changes or to restore the balance of intestinal flora, which occurs. occurs after the selective effect of antibiotics, especially broad-spectrum antibiotics.
Due to its resistance to antibiotics, Bacillus clausii can be taken in between two doses of antibiotics. The antibiotics mentioned included: penicillins, cephalosporins, tetracyclines, macrolides, aminoglycosides, novobiocin, chloramphenicol, thiamphenicol, lincomycin, isoniazid, cycloserine, rifamplcin, nalidixic acid and pipemidic acid.
15. Pharmacokinetic properties
NA
16. Packaging
Box of 20 tubes x 5 ml with instructions for use.
17. Storage conditions, expiration date, and quality standards of the drug
Storage: Cool and dry place, protect from light, temperature below 30oC.
Shelf life: 2 years.
Quality standards of drugs: In house
18. Name and address of the drug manufacturing facility
Euro Santé Pharmaceutical Joint Stock Company
Song Cung industrial site, Dong Thap commune, Dan Phuong district, Hanoi city, Vietnam.